Have We Lost the Cannabis Legalization War?

Listen to Dr. Kevin Sabet’s discussion on High Truths on
Drugs and Addiction, Episode #23

Have we lost the cannabis legalization war? This is a question posed to Dr. Kevin Sabet, IASIC Advisor, former White House Advisor, and president and CEO of SAM, Smart Approaches to Marijuana. Listen to his expertise on High Truths on Drugs and Addiction, Episode #23.

Is there even a war on drugs anymore? How can people in prevention go against a billion-dollar marijuana goliath industry? Dr. Sabet has a thoughtful conversation with Dr. Roneet Lev on High Truths.

Listen Now

About Kevin Sabet, PhD
An affiliate of the Institution for Social and Policy Studies and the Medical School at Yale University, and dubbed by NBC News as the “prodigy of drug politics,” author, consultant, and advisor to three U.S. presidential administrations, Kevin A. Sabet, Ph.D., has studied, researched, written about, and implemented drug policy for 25 years. He is currently the President and CEO of SAM (Smart Approaches to Marijuana), a non-profit organization he founded with Congressman Patrick Kennedy and David Frum. His latest book, Smokescreen: What the Marijuana Industry Doesn’t Want You to Know, is distributed by Simon & Schuster. He is the only person appointed by Republicans and Democrats to work at the White House drug office, and he is a columnist for Newsweek. He received his doctorate from Oxford University.

Listen to Episode #23 Now

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org

Visit the IASIC Library here. The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on Linkdin
Share on pinterest
Share on Pinterest

Leave a comment

Related Posts

Sentinel Surveillance of Substance-Related Poisonings in Canada: Spotlight on Cannabis

Substance-related poisonings and injuries in Canada have received increasing attention in recent years due to emerging public health concerns, such as the opioid overdose crisis, the introduction of synthetic cannabinoids to the illicit market and the emergence of electronic cigarettes/vaping products on the Canadian market. Furthermore, there has been a general increase in substance-related hospitalizations

Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017

There are distinct patterns of hospitalizations due to cannabis harms in different priority populations. Young women aged 15 to 24 are a key demographic that is disproportionately burdened with a rapid increase in hospitalizations due to cannabis harms. Jurisdictions considering new approaches to cannabis control policy and addiction services should consider the rising burden of

Cannabis and Psychosis: Recent Epidemiological Findings Continuing the “Causality Debate”

Nonmedical (“recreational”) cannabis use and cannabis laws have changed over the past two decades in the United States (1) and the rest of the world (2). Increasing use, especially among the young, coupled with the increasing potency of cannabis (higher delta-9-tetrahydrocannabinol [THC] content) during this period (3), has raised concerns about the long-term health impact

Scroll to Top